Clinical outcomes following ibrutinib and idelalisib-based therapy in CLL: A retrospective analysis

Type of Cancer
Lymphoma

Site
Hackensack

Sponsor
Hackensack UMC

Protocol Number
Hackensack UMC PRO 00005855

To Learn More Call
201-510-0910